C12Q 1/6811
Selection methods for production or design of target specific oligonucleotides or binding
Official title: Selection methods for production or design of target specific oligonucleotides or binding molecules
C12Q1/6811 (Selection methods for production or design of target specific oligonucleotides or binding) appears on 930 US grants and 1,066 published applications in this corpus.
Search patents in C12Q- Granted patents
- 930
- Published applications
- 1,066
- Assignees
- 516
- Inventors
- 1,943
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 19 | 0 |
| 1997 | 43 | 0 |
| 1998 | 77 | 0 |
| 1999 | 41 | 0 |
| 2000 | 57 | 0 |
| 2001 | 59 | 11 |
| 2002 | 57 | 67 |
| 2003 | 43 | 78 |
| 2004 | 25 | 51 |
| 2005 | 13 | 40 |
| 2006 | 20 | 27 |
| 2007 | 6 | 22 |
| 2008 | 9 | 16 |
| 2009 | 7 | 25 |
| 2010 | 10 | 27 |
| 2011 | 18 | 25 |
| 2012 | 14 | 24 |
| 2013 | 18 | 23 |
| 2014 | 9 | 23 |
| 2015 | 21 | 33 |
| 2016 | 18 | 29 |
| 2017 | 19 | 39 |
| 2018 | 21 | 69 |
| 2019 | 35 | 72 |
| 2020 | 38 | 59 |
| 2021 | 53 | 54 |
| 2022 | 44 | 62 |
| 2023 | 23 | 46 |
| 2024 | 42 | 63 |
| 2025 | 30 | 50 |
| 2026 | 32 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for simultaneous amplification of target loci6 Oct 2026US 12,753,438 B2Natera, Inc.
- Tumor marker stamp-EP3 based on methylation modification29 Sep 2026US 12,747,477 B2Shanghai Epiprobe Biotechnology Co., Ltd.
- Genotyping by sequencing22 Sep 2026US 12,742,195 B2Regeneron Pharmaceuticals, Inc.
- Methods for simultaneous amplification of target loci15 Sep 2026US 12,735,746 B2Natera, Inc.
- Methods for simultaneous amplification of target loci15 Sep 2026US 12,735,748 B2Natera, Inc.
- Methods of selecting primers for amplification of target sequences8 Oct 2026US 2026/0308665 A1Ribbon Bio GmbH
- Method for constructing molecular sum gates using padlock probes for quantitating nucleic acid targets sums17 Sep 2026US 2026/0275420 A1Algorithmic Biologics Private Limited
- Rna-directed dna cleavage by the cas9-crrna complex10 Sep 2026US 2026/0265750 A1Vilnius University
- Target reporter constructs and uses thereof27 Aug 2026US 2026/0250742 A1RedVault Biosciences, LP
- Amplicon-based approach for detecting differences in human dna fragmentation patterns between cancer and non-cancer samples6 Aug 2026US 2026/0226555 A1The Translational Genomics Research Institute
Most cited
By later US patents
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998
- DNA mutagenesis by random fragmentation and reassembly791US 5,830,721 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination707US 5,811,238 AAffymax Technologies N.V. · 1998